Published in Australasian Journal of Neuroscience
Dystonia is a neurological movement disorder characterised by abnormal and involuntary twisting movements and postures. It comes in many forms and can affect various parts of the body. Dystonia is seen in children and adults as a standalone condition, or as one part of a complex disease. Dystonia can be caused by genetic mutations, specific medicat...
Published in Australasian Journal of Neuroscience
Published in Australasian Journal of Neuroscience
Lewy Body Dementia (LBD) is an umbrella term for two dementia subtypes Dementia with Lewy Bodies (DLB) and Parkinson’s Disease Dementia (PDD) (Armstrong et al., 2020a; Larrson et al., 2019). Despite being the second most common type of dementia after Alzheimer’s Disease (AD), 1 in 3 cases of LBD are believed to be missed or misdiagnosed (Armstrong ...
Published in Australasian Journal of Neuroscience
Published in Australasian Journal of Neuroscience
Pembrolizumab is a monoclonal antibody programmed cell death 1 inhibitor that is an established treatment for melanoma and various lung cancers. Whilst an effective treatment option, it is known to have multiple immune related adverse events associated with its use, including neurological complications such as myasthenia gravis. Previous case repor...
Published in Australasian Journal of Neuroscience
Background The Coronavirus 2019 (COVID-19) pandemic has affected the delivery of healthcare around the world. We assessed the impact of the COVID-19 pandemic on hospital presentations, reperfusion treatment and outcomes in a comprehensive stroke centre. Methods In this observational study seven months of retrospective data from February 2020 (at th...
Published in Australasian Journal of Neuroscience
Published in Australasian Journal of Neuroscience
Collectively, Lewy Body Dementia (LBD) including Parkinson’s Disease Dementia (PDD) and dementia with Lewy Bodies (DLB) account for the second leading type of dementia following Alzheimer’s disease (AD) (Lee et al., 2019). Despite revised consensus criteria, detection rates in routine clinical practice remain poor (Vann Jones & O’Brien, 2013) with ...
Published in Australasian Journal of Neuroscience
Published in Australasian Journal of Neuroscience
This article outlines a research protocol for investigating the health care experiences of people living with Myotonic Dystrophy Type 1 (Dytrophia Myotonica; DM1). Introduction DM1 is a neuromuscular condition of highly variable presentation across the lifespan. It is a complex and variable condition which impacts many body systems. Care consensus,...
